CX-3543

DRUG2 trials

Sponsors

Cylene Pharmaceuticals

Conditions

Advanced Solid TumorsB-Cell Chronic Lymphocytic LeukemiaLymphoma

Phase 1

Dose-escalation Study of CX-3543 in Patients With Advanced Solid Tumors or Lymphomas

CompletedNCT00955786

Cylene PharmaceuticalsAdvanced Solid Tumors, Lymphoma

Start: 2005-07-31End: 2008-12-31Updated: 2009-08-10

Phase 2

Study Evaluating Effects of CX-3543 in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia

WithdrawnNCT00485966

Cylene PharmaceuticalsB-Cell Chronic Lymphocytic Leukemia

Start: 2007-06-30End: 2008-06-30Target: 25Updated: 2008-11-05